Details for New Drug Application (NDA): 215615
✉ Email this page to a colleague
The generic ingredient in METHAZOLAMIDE is methazolamide. There are seven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the methazolamide profile page.
Summary for 215615
Tradename: | METHAZOLAMIDE |
Applicant: | Tagi |
Ingredient: | methazolamide |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 215615
Suppliers and Packaging for NDA: 215615
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
METHAZOLAMIDE | methazolamide | TABLET;ORAL | 215615 | ANDA | TAGI Pharma, Inc. | 51224-024 | 51224-024-50 | 100 TABLET in 1 BOTTLE (51224-024-50) |
METHAZOLAMIDE | methazolamide | TABLET;ORAL | 215615 | ANDA | TAGI Pharma, Inc. | 51224-124 | 51224-124-50 | 100 TABLET in 1 BOTTLE (51224-124-50) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 25MG | ||||
Approval Date: | Oct 18, 2022 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 50MG | ||||
Approval Date: | Oct 18, 2022 | TE: | AB | RLD: | No |
Complete Access Available with Subscription